In their own responses to the senators’ inquiries last fall, both Pfizer and Lilly emphasized the independence of their ...

Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program ...

U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...

"I can say without a shadow of a doubt, outside of God's grace, for me Cristo Rey was the 'jet setter' of the path I'm on ...

Network highlights graduates shaping the fields of law, banking, finance, education, health care, media, science, technology ...

Results of positron emission tomography (PET) trial and second multiple ascending dose (MAD-2) trial support RAP-219's transformative potential ...

Stock splits tend to create a lot of buzz in the market, especially when some of the most prominent companies announce a ...

Hims & Hers Health will shut down Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is being shut down to “simplify its (company’s) dermatology ...

Eli Lilly Chief Executive David Ricks annual compensation rose to $29.2 million in 2024, a 10% increase from the $26.2 million he received a year earlier.